Conferences-Presentations

• AAPS Workshop on Pharmacogenetics in Individualized Medicine: Methods, Regulatory and Clinical Applicationspresentation, Nov 16-20, 2008, Georgia World Congress Center, Atlanta, Georgia. Speaking presentation "Role Of Accelerator Mass Spectrometry (AMS) in Phytochemical Research" by Dr. Stephen R. Dueker.

• The 2nd Pediatric Clinical Trials: Using a Multi-Disciplinary Organizational Approach for Running Efficient Trials and Responding to Regulation - October 16th-17th, 2008 - Gaylord National Resort & Convention Center on the Potomac, MD.  Speaking Presentation "The Technical Advantages of AMS for Pediatric Drug Development" by Dr. Le Thuy Vuong.

• AAPS Workshop on Drug Discovery Strategies and Critical Issues for Clinical Candidate Selection on May 19 - 21, 2008 in South San Francisco Conference Center South San Francisco, California. Speaking presentation "Accelerator MS and Microdosing for Human Metabolism, PK, and Target Confirmation" by Dr. John Vogel.

• CACO-CA luncheon seminar at the Crown Plaza Hotel in Foster City, CA in March 21, 2008 from 11:00am to 1:pm. - Keynote address "Exploring human physiochemistry of candidate compounds early in drug development" by Dr. John Vogel.

• Conference:  IBC's Inaugural "From Discovery to IND: Scientific Strategies and Processes to Improve your Chances of Success - March 13-14, 2007 * Sheraton Inner Harbor * Baltimore, MD.  Open-floor discussion on "Microdosing and AMS - a Discussion of 'Why' and 'When" Microdosing is essential' " by John Vogel and Le Vuong of Vitalea Science, Inc. 

• Pre-Conference Short Course on Microdosing by  Drs. Stephen Dueker, John Vogel and Preston Baecker of Vitalea Science, Inc.during the 14th International Molecular Tri-Conference, February 27 at the Moscone North Conventional Center, San Francisco, California. 

• Conference: The 7th Annual Phase I Clinical Trials, October 11-13, 2006 at the Red Rock Resort and Spa, Las Vegas, NV. Presentation by Stephen R. Dueker "Creating a Standardized Approach and Tackling the Challenges of Microdosing".  

• Conference: CBI's 6th Forum on Predictive ADME/TOX , Sept. 27-29, 2006 at the Hamilton Crowne Plaza Hotel in Washington DC. Presentation by Dr. Stephen Dueker "Microdosing and Accelerator Mass Spectrometry - Reality and Possibility".

• Conference: "Ninth International Symposium on the Synthesis and Applications of Isotopically Labelled Compounds", from July 16th to 20th 2006 at the Edinburgh International Conference Centre, Edinburgh Scotland. Presentation by Dr. John Vogel, Chief Scientific Officer of Vitalea Science, Inc: 
  • "AMS quantification of target tissue delivery using human microdose exposures" on Wednesday 19 July from 16.15 to 16.35hrs; 
  • "Natural synthesis of difficult products with low 14C labeling for AMS studies" - Poster Presentation; 
  • "Quantifying bone involvement in disease states using 41Ca" - Poster Presentation; 
  • "Skeletal contribution to neutralizing human phosphate intake" - Poster Presentation;

   

• Conference "Drug Development from Animals Models to Phase I", April 10-11, 2006. Doubletree Hotel, Philadelphia, Philadelphia, PA. "Attomolar Quantitation Uisng Massless Doses - How AMS and Microdosing can advance Drug Development" by Stephen R. Dueker, Ph.D., Vitalea Science, Inc. 
• Presentation at Preclinical Development Forum, March 20-22, 2006 - "Getting Human PK Data Early On by Microdosing and Accelerator Mass Spectrometry" by Le T. Vuong, Ph.D., Vitalea Science, Inc. Click here for brochure. 
• Presentation at The Premier Conference on Phase 0/Early Human Data conference, January 18-20,2006 - "Microdosing and Beyond: An Evaluation of Two Antiretrovirals at Microdose Concentrations" by Dr. Stephen R. Dueker, Ph.D., Vitalea Science, Inc. Click here for brochure.
• Presentation at WorldNutra2005 Conference, October 16-19, 2005 - "Accelerator Mass Spectrometry: A new tool for human metabolism studies of Nutraceuticals and Functional Foods" by Dr. Le Thuy Vuong, Vitalea Science, Inc. 
• Conference: "Phase 0/1 Studies Making Earlier Decisions in Discovery, Preclinical, Clinical Research & Operations" - Hamilton Crowne Plaza Washington, DC, September 1-23, 2005. Panel Discussion "Exploratory IND" - Moderator: Bruce Morimoto, PhD, Director of Drug Development Programs, MDS. Panel Members: Robert Butz, PhD, Vice President, Global Regulatory Affairs, MDS Pharma Services Timothy J. McCarthy, Associate Director Global Clinical Platforms, Pfizer Global R&D Colin Garner, BPharm, PhD, DSc, FRCath, Chief Executive Officer, Xceleron; Stephen R. Dueker, PhD, President, Vitalea Science; Jean-Michel Gries, PhD, US Head of Clinical Pharmacology, Hoffmann-La Roche Rakesh Dixit, PhD, Associate Director, Merck & Co. Steve Ritland, PhD, MBA, Director Global Exploratory Development, Roche Pharmaceutical.
•   The 10th International Conference on Accelerator Mass Spectrometry, Berkeley, California, September 5-10, 2005 (AMS10) - "New Tools for Clinical Pharmacology - a Microdose Study of a New Class of Anti-HIV Compounds", Presenter: Dr. Stephen Dueker, President of Vitalea Science, Inc. Click here to view ABSTRACT
• Presentation: Early Phase Clinical Development Scientific Symposium. Hosted by Radiant Research, Inc.. San Diego , May 12-13. “Quantitative ADME via Acclerator Mass Spectrometry". Presenter: Dr. Stephen R. Dueker.
•     Fourth SETAC World Congress, 14-18 November 2004, Portland, Oregon, USA - Use of Accelerator Mass Spectrometry as a tool for wildlife metabolism and biomarker studies, using Japanese quail as a model - Faulkner, B. Wilson, B. Vogel , J. Dueker, S.  University of California , Davis, Davis , CA , USA ;  Lawrence Livermore National Laboratory, Livermore , CA , USA ;  Vitalea Sciences, Inc, Davis , CA , USA . 
•     WorldNutra 2004 Conference, November 7-10, 2004 San Francisco, CA, USA: Poster Presentation - Big physics Demystifies the Pharmacology of Nutraceuticals and Functional Foods: Accelerator Mass Spectrometry for Human Metabolism Studies - Le T. Vuong and Stephen R. Dueker - Departments of Nutrition, University of California,Davis and Vitalea Science, Inc., Davis, CA. Click here to see  ABSTRACT
•     Bruce Ames International Symposium on Nutritional Genomics October 22-24, 2004 University of California, Davis: Poster Presentation - Biological Accelerator Mass Spectrometry (Bio-AMS) in phytonutrition S.R. Dueker, L.T. Vuong - Vitalea Science, Inc. Davis, California and Nutrition Department, University of California, Davis. Click here to see  ABSTRACT
•     Preclinical Development Forum - Predictive and Translational Medicine: From Discovery to the Clinic.  October 4-6, 2004: Poster Presentation -  Accelerator Mass Spectrometry as a tool for preclinical metabolism studies using ambient levels of radioactivity -  Brian Faulkner, Barry W Wilson, Bill L. Lasley, John S. Vogel and Stephen R. Dueker  -  Department of Animal Science and Center for Health and the Environment, University of California, Davis, CA; Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, CA; Vitalea Science, Inc. Davis, CA, USA.  Click here to see  ABSTRACT
•     Drug Discovery Technology Conference - August 8-12, 2004: Poster Presentation - Quantitative ADME using 'massless' doses: New applications for biological Accelerator Mass Spectrometry - Stephen Dueker, Ph.D., Vitalea Science, Inc. Click here to see  ABSTRACT